
What the $1b Roche-PathAI Deal Can Tell Clinical Lab Directors
Roche acquires a workflow rather than a company, says AI industry observer

Roche acquires a workflow rather than a company, says AI industry observer

Biotech giant purchased the company for $21 billion, one of the largest deals in clinical lab history

It is acquiring Bako Diagnostics and StrataDx for a combined $55.5 million

Agreement is part of the Natera’s aggressive growth model as it strives to turn a profit

Labcorp will acquire oncology-related clinical tests services from BioReference’s parent company, OPKO Health